
About Touchlight
Touchlight is a company based in Hampton (United Kingdom) founded in 2007 by Jonny Ohlson. Touchlight has raised $190.09 million across 7 funding rounds from investors including Gates Foundation, Downing and Bridford Group. The company has 158 employees. Touchlight offers products and services including dbDNA and GMP dbDNA Supply. Touchlight operates in a competitive market with competitors including Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others.
- Headquarter Hampton, United Kingdom
- Employees 158
- Founders Jonny Ohlson
- Stage Minicorn
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website touchlight.com
- Social LinkedIn X Facebook
- Legal Name Touchlight Genetics Limited
- Date of Incorporation 08 Nov, 2007
- Jurisdiction HAMPTON, ENGLAND
- Annual Revenue$5.42 M (USD)-72as on Dec 31, 2023
- Net Profit-$60.58 M (USD)-509as on Dec 31, 2023
- EBITDA-$62.24 M (USD)-370as on Dec 31, 2023
- Total Equity Funding$190.09M (USD)
in 7 rounds
- InvestorsGates Foundation
& 3 more
- Employee Count158
Products & Services of Touchlight
Touchlight offers a comprehensive portfolio of products and services, including dbDNA and GMP dbDNA Supply.
Enables rapid, scalable DNA production for genetic medicines.
Provides high-purity DNA as drug substance for clinical use.
Funding Insights of Touchlight
Touchlight has successfully raised a total of $190.09M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $190.09M
- Total Rounds 7
- Investors Count 4
All 7 funding rounds of Touchlight with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | – | Grant | β | β | |
| Jan 2021 | $178.53M | Series B | $652.45M | Bridford Group, Novator Partners | β |
| Apr 2017 | $3.04M | Series A | $100.39M | β | β |
| Oct 2016 | $2.63M | Series A | $β’β’β’β’β’ | β | β |
| Jul 2015 | $4.98M | Series A | $β’β’β’β’β’ | β | β |
| Feb 2015 | $911,065 | Series A | $β’β’β’β’β’ | β | β |
| Oct 2014 | – | Series A | β | β |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2021 | $652.45M | β’β’β’β’β’β’β’β’ |
| Apr 2017 | $100.39M | β’β’β’β’β’β’β’β’ |
| Oct 2016 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
| Jul 2015 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
| Feb 2015 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
Full valuation and stage history of Touchlight
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $652.45M (Jan 2021). 4 investors in total: 4 institutional.
Investors in Touchlight
Touchlight has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation, Downing and Bridford Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage tech companies are invested in by Bridford Group. | – | bridfordgroup.com | London, United Kingdom | |
Private equity investments in Europe are managed by Novator Partners. | – | novator.co.uk | London, United Kingdom | |
Inheritance tax relief, funds, and bonds are provided across sectors. | 1986 | downing.co.uk | London, United Kingdom | |
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States |
Investor details for Touchlight
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Touchlight
3 people are tracked at Touchlight (3 in leadership); the tracked headcount is 158.
| Name | Role | Group |
|---|---|---|
Jonny Ohlson | Founder & Co-CEO | Leadership |
Antonio Marques | Chief Operating Officer | Leadership |
Karen Fallen | Co-CEO | Leadership |
Complete people profiles for Touchlight
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Touchlight
4 dated milestones of Touchlight across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Touchlight is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Grant,.
Competitors of Touchlight
Touchlight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amyris.com | 2003 | Emeryville, United States | $487.2M | 747 | Developer of renewable products for industrial solutions | |
| inscripta.io | 2015 | Helsinki, Finland | $853,384 | – | Speech recognition solutions are provided by Inscripta for healthcare professionals. | |
| pivotbio.com | 2010 | Berkeley, United States | $618.08M | 256 | Nitrogen-fixing microbes for corn crop nutrition are developed and applied. | |
| ginkgobioworks.com | 2008 | Boston, United States | $795.75M | 1,218 | Gene editing-based cultured ingredients are provided for agriculture. | |
| syngenta.com | 2000 | Basel, Switzerland | – | – | Crop protection solutions and hybrid seeds are provided for farming. | |
| asimov.com | 2017 | Boston, United States | $209.4M | 87 | Provider of integrated suite for advanced genetic design and manufacturing | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| askbio.com | 2001 | Durham, United States | $235M | – | Gene and protein therapies are developed for treating various diseases. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of Touchlight
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Touchlight
The website of Touchlight (touchlight.com) receives about 6.3K visits a month and ranks #4,432,265 among all websites worldwide, #5,380 in Biotechnology and Pharmaceuticals.
- Monthly visits6.3K
▲ 53.3% vs previous month
- Unique visitors1.8K
per month
- Global rank#4,432,265
among all websites
- Category rank#5,380
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit1.6
- Average visit15 sec
- DevicesDesktop 37% Β· Mobile 63%
Websites whose visitors overlap most with Touchlight. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| quell-tx.com | 100% | 5.4K | #2,821,396 | View details | |
| orchard-tx.com | 91% | 6.7K | #2,566,805 | View details | |
| exactsciences.com | 46% | 546.4K | #82,917 | View details | |
| lbic.com | 29% | – | #4,573,435 | View details | |
| insightbio.com | 28% | 5K | #3,682,821 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 8 similar websites and full traffic analytics for Touchlight
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Touchlight
Complete news archive for Touchlight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Touchlight
10 companies that operate in the same segment as Touchlight (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Touchlight
Touchlight was founded in 2007 and raised its 1st funding round 7 years after it was founded.
Touchlight is headquartered in Hampton, United Kingdom. It is registered at Hampton, Greater London, United Kingdom.
Jonny Ohlson is the current CEO of Touchlight. They have also founded this company.
Touchlight is a funded company, having raised a total of $190.09M across 7 funding rounds to date.
Touchlight has 158 employees.
Annual revenue of Touchlight is $5.42M as on Dec 31, 2023.
Touchlight was founded in 2007 and is based in Hampton, United Kingdom. A proprietary cell-free DNA technology platform is offered by the company for applications in genetic medicine. Enzymatic manufacturing solutions are utilized to produce doggy bone DNA vectors. These support mRNA therapeutics, AAV and lentiviral vectors, gene editing, non-viral therapies, and DNA vaccines within the biotechnology sector.
Touchlight offers dbDNA and GMP dbDNA Supply.
Touchlight has 4 investors. Key investors include Gates Foundation, Downing, Bridford Group, and Novator Partners.
The valuation of Touchlight is $652.45M as of Jan 2021.
Touchlight operates through Touchlight Genetics Limited.
